Journal of Clinical Endocrinology & Metabolism, Vol 79, 1735-1741, Copyright © 1994 by Endocrine Society

ARTICLES

The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy

M Westwood, JM Gibson, AJ Davies, RJ Young and A White
Department of Medicine, University of Manchester, United Kingdom.

We have determined the phosphorylation pattern of circulating insulin- like growth factor-binding protein-1 (IGFBP-1) in normal subjects and assessed how this changes in pregnancy. Two RIAs employing different monoclonal antibodies (MAbs 6303 or 6305) were used to measure IGFBP-1. In normal subjects, RIA 6303 measured 11-fold higher levels than RIA 6305 (72.8 vs. 6.6 micrograms/L; P < 0.008). However, in amniotic fluid (AF), the two assays gave similar results. Immunoprecipitation of plasma and AF with MAb 6303 and 6305 before nonsodium dodecyl sulfate- electrophoresis and Western ligand blotting revealed different IGFBP-1 isoforms and differential antibody recognition as the cause of this discrepancy. In AF, both MAbs precipitated nonphosphorylated and phosphorylated isoforms, whereas in plasma, only a single highly phosphorylated species, not seen in AF, was observed. This form of IGFBP-1 was precipitated by MAb 6303 only. During pregnancy, the phosphorylation state of IGFBP-1 in the maternal circulation was altered, as nonphosphorylated IGFBP-1 and three lesser phosphoforms were also observed. The appearance of these other variants resulted in a significant increase in IGFBP-1 measured by RIA 6305 (37, 51, and 83 micrograms/L in first, second, and third trimesters, respectively; P < 0.0005 vs. controls). The changes in IGFBP-1 phosphorylation induced by pregnancy may influence the modulatory effects of IGFBP-1 on IGF bioavailability and, hence, fetal growth.

This article has been cited by other articles:

				M. Nissum, M. Abu Shehab, U. Sukop, J. M. Khosravi, R. Wildgruber, C. Eckerskorn, V. K. M. Han, and M. B. Gupta Functional and Complementary Phosphorylation State Attributes of Human Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) Isoforms Resolved by Free Flow Electrophoresis Mol. Cell. Proteomics, June 1, 2009; 8(6): 1424 - 1435. [Abstract] [Full Text] [PDF]

				M. Hansen, B. F. Miller, L. Holm, S. Doessing, S. G. Petersen, D. Skovgaard, J. Frystyk, A. Flyvbjerg, S. Koskinen, J. Pingel, et al. Effect of administration of oral contraceptives in vivo on collagen synthesis in tendon and muscle connective tissue in young women J Appl Physiol, April 1, 2009; 106(4): 1435 - 1443. [Abstract] [Full Text] [PDF]

				M. D. Seferovic, R. Ali, H. Kamei, S. Liu, J. M. Khosravi, S. Nazarian, V. K. M. Han, C. Duan, and M. B. Gupta Hypoxia and Leucine Deprivation Induce Human Insulin-Like Growth Factor Binding Protein-1 Hyperphosphorylation and Increase Its Biological Activity Endocrinology, January 1, 2009; 150(1): 220 - 231. [Abstract] [Full Text] [PDF]

				L. Holm, S. Reitelseder, T. G. Pedersen, S. Doessing, S. G. Petersen, A. Flyvbjerg, J. L. Andersen, P. Aagaard, and M. Kjaer Changes in muscle size and MHC composition in response to resistance exercise with heavy and light loading intensity J Appl Physiol, November 1, 2008; 105(5): 1454 - 1461. [Abstract] [Full Text] [PDF]

				M. Hansen, S. O. Koskinen, S. G. Petersen, S. Doessing, J. Frystyk, A. Flyvbjerg, E. Westh, S. P. Magnusson, M. Kjaer, and H. Langberg Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exercise J. Physiol., June 15, 2008; 586(12): 3005 - 3016. [Abstract] [Full Text] [PDF]

				U Berg, T Gustafsson, C J Sundberg, L Kaijser, C Carlsson-Skwirut, and P Bang Interstitial IGF-I in exercising skeletal muscle in women Eur. J. Endocrinol., October 1, 2007; 157(4): 427 - 435. [Abstract] [Full Text] [PDF]

				K. Ekstrom, J. Salemyr, I. Zachrisson, C. Carlsson-Skwirut, E. Ortqvist, and P. Bang Normalization of the IGF-IGFBP Axis by Sustained Nightly Insulinization in Type 1 Diabetes Diabetes Care, June 1, 2007; 30(6): 1357 - 1363. [Abstract] [Full Text] [PDF]

				V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF]

				C. S. Watson, P. Bialek, M. Anzo, J. Khosravi, S.-P. Yee, and V. K. M. Han Elevated Circulating Insulin-Like Growth Factor Binding Protein-1 Is Sufficient to Cause Fetal Growth Restriction Endocrinology, March 1, 2006; 147(3): 1175 - 1186. [Abstract] [Full Text] [PDF]

				K. Stokes, M. Nevill, J. Frystyk, H. Lakomy, and G. Hall Human growth hormone responses to repeated bouts of sprint exercise with different recovery periods between bouts J Appl Physiol, October 1, 2005; 99(4): 1254 - 1261. [Abstract] [Full Text] [PDF]

				M. Kabir-Salmani, Y. Shimizu, K. Sakai, and M. Iwashita Posttranslational modifications of decidual IGFBP-1 by steroid hormones in vitro Mol. Hum. Reprod., September 1, 2005; 11(9): 667 - 671. [Abstract] [Full Text] [PDF]

				A. Sala, S. Capaldi, M. Campagnoli, B. Faggion, S. Labo, M. Perduca, A. Romano, M. E. Carrizo, M. Valli, L. Visai, et al. Structure and Properties of the C-terminal Domain of Insulin-like Growth Factor-binding Protein-1 Isolated from Human Amniotic Fluid J. Biol. Chem., August 19, 2005; 280(33): 29812 - 29819. [Abstract] [Full Text] [PDF]

				D. K. Tisi, X.-J. Liu, L. J. Wykes, C. D. Skinner, and K. G. Koski Insulin-Like Growth Factor II and Binding Proteins 1 and 3 from Second Trimester Human Amniotic Fluid Are Associated with Infant Birth Weight J. Nutr., July 1, 2005; 135(7): 1667 - 1672. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. Frystyk, A. Iranmanesh, and H. Orskov Testosterone and Estradiol Regulate Free Insulin-Like Growth Factor I (IGF-I), IGF Binding Protein 1 (IGFBP-1), and Dimeric IGF-I/IGFBP-1 Concentrations J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2941 - 2947. [Abstract] [Full Text] [PDF]

				C. A. Hedman, J. Frystyk, T. Lindstrom, J.-W. Chen, A. Flyvbjerg, H. Orskov, and H. J Arnqvist Residual {beta}-Cell Function More than Glycemic Control Determines Abnormalities of the Insulin-Like Growth Factor System in Type 1 Diabetes J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6305 - 6309. [Abstract] [Full Text] [PDF]

				K. Kaushal, A. H. Heald, K. W. Siddals, M. S. Sandhu, D. B. Dunger, J. M. Gibson, and N. J. Wareham The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome Diabetes Care, November 1, 2004; 27(11): 2682 - 2688. [Abstract] [Full Text] [PDF]

				M. S. Sandhu, J. M. Gibson, A. H. Heald, D. B. Dunger, and N. J. Wareham Association between Insulin-Like Growth Factor-I: Insulin-Like Growth Factor-Binding Protein-1 Ratio and Metabolic and Anthropometric Factors in Men and Women Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 166 - 170. [Abstract] [Full Text] [PDF]

				H. Honkanen, E.-M. Rutanen, and O. Heikinheimo Differential kinetics of serum and cervical insulin-like growth factor-binding protein-1 during mifepristone-misoprostol-induced medical termination of early pregnancy Mol. Hum. Reprod., January 1, 2004; 10(1): 65 - 70. [Abstract] [Full Text] [PDF]

				H. Norrelund, J. Frystyk, J. O. L. Jorgensen, N. Moller, J. S. Christiansen, H. Orskov, and A. Flyvbjerg The Effect of Growth Hormone on the Insulin-Like Growth Factor System during Fasting J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3292 - 3298. [Abstract] [Full Text] [PDF]

				R. Amin, C. Schultz, K. Ong, J. Frystyk, R. N. Dalton, L. Perry, H. Orskov, and D. B. Dunger Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study Diabetes Care, May 1, 2003; 26(5): 1456 - 1461. [Abstract] [Full Text] [PDF]

				G. E. Krassas, N. Pontikides, T. Kaltsas, A. Dumas, J. Frystyk, J. W. Chen, and A. Flyvbjerg Free and Total Insulin-Like Growth Factor (IGF)-I, -II, and IGF Binding Protein-1, -2, and -3 Serum Levels in Patients with Active Thyroid Eye Disease J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 132 - 135. [Abstract] [Full Text] [PDF]

				A. H. Heald, K.W. Siddals, W. Fraser, W. Taylor, K. Kaushal, J. Morris, R. J. Young, A. White, and J. M. Gibson Low Circulating Levels of Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Are Closely Associated With the Presence of Macrovascular Disease and Hypertension in Type 2 Diabetes Diabetes, August 1, 2002; 51(8): 2629 - 2636. [Abstract] [Full Text] [PDF]

				M. Soop, H. Duxbury, A. O Agwunobi, J. M. Gibson, S. J. Hopkins, C. Childs, R. G. Cooper, P. Maycock, R. A. Little, and G. L. Carlson Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1276 - E1285. [Abstract] [Full Text] [PDF]

				E. Kajantie, L. Dunkel, E.-M. Rutanen, M. Seppala, R. Koistinen, A. Sarnesto, and S. Andersson IGF-I, IGF Binding Protein (IGFBP)-3, Phosphoisoforms of IGFBP-1, and Postnatal Growth in Very Low Birth Weight Infants J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2171 - 2179. [Abstract] [Full Text] [PDF]

				J. Frystyk, K. Hojlund, K. N. Rasmussen, S. P. Jorgensen, M. Wildner-Christensen, and H. Orskov Development and Clinical Evaluation of a Novel Immunoassay for the Binary Complex of IGF-I and IGF-Binding Protein-1 in Human Serum J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 260 - 266. [Abstract] [Full Text] [PDF]

				M. Westwood, J. D. Aplin, I. A. Collinge, A. Gill, A. White, and J. M. Gibson alpha 2-Macroglobulin: a New Component in the Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-1 Axis J. Biol. Chem., November 2, 2001; 276(45): 41668 - 41674. [Abstract] [Full Text] [PDF]

				J. K. Cruickshank, A. H. Heald, S. Anderson, J. E. Cade, J. Sampayo, L. K. Riste, A. Greenhalgh, W. Taylor, W. Fraser, A. White, et al. Epidemiology of the Insulin-like Growth Factor System in Three Ethnic Groups Am. J. Epidemiol., September 15, 2001; 154(6): 504 - 513. [Abstract] [Full Text] [PDF]

				M. Westwood, J.M. Gibson, S. R. Sooranna, S. Ward, J. P. Neilson, and R. Bajoria Genes or placenta as modulator of fetal growth: evidence from the insulin-like growth factor axis in twins with discordant growth Mol. Hum. Reprod., April 1, 2001; 7(4): 387 - 395. [Abstract] [Full Text] [PDF]

				J.M. Gibson, J.D. Aplin, A. White, and M. Westwood Regulation of IGF bioavailability in pregnancy Mol. Hum. Reprod., January 1, 2001; 7(1): 79 - 87. [Abstract] [Full Text] [PDF]

				M. H. Aguiar-Oliveira, M. S. Gill, E. S. de, A. Barretto, M. R. S. Alcântara, F. Miraki-Moud, C. A. Menezes, A. H. O. Souza, C. E. Martinelli, F. A. Pereira, et al. Effect of Severe Growth Hormone (GH) Deficiency due to a Mutation in the GH-Releasing Hormone Receptor on Insulin-Like Growth Factors (IGFs), IGF-Binding Proteins, and Ternary Complex Formation Throughout Life J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4118 - 4126. [Abstract] [Full Text]

				D. Fowler, G. Albaiges, C. Lees, J. Jones, K. Nicolaides, and J. Miell The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by Doppler ultrasound Hum. Reprod., November 1, 1999; 14(11): 2881 - 2885. [Abstract] [Full Text] [PDF]

				R. A. Frost and C. H. Lang Differential Effects of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-1 on Protein Metabolism in Human Skeletal Muscle Cells Endocrinology, September 1, 1999; 140(9): 3962 - 3970. [Abstract] [Full Text]

				J. A. M. J. L. Janssen, R. P. Stolk, H. A. P. Pols, D. E. Grobbee, and S. W. J. Lamberts Serum Total IGF-I, Free IGF-I, and IGFBP-1 Levels in an Elderly Population : Relation to Cardiovascular Risk Factors and Disease Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 277 - 282. [Abstract] [Full Text] [PDF]

				J. Frystyk, T. Grofte, C. Skjarbak, and H. Orskov The Effect of Oral Glucose on Serum Free Insulin-Like Growth Factor-I and -II in Healthy Adults J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3124 - 3127. [Abstract] [Full Text] [PDF]

				N. A. Martina, E. Kim, U. Chitkara, N. C. Wathen, T. Chard, and L. C. Giudice Gestational Age-Dependent Expression of Insulin-Like Growth Factor-Binding Protein-1 (IGFBP-1) Phosphoisoforms in Human Extraembryonic Cavities, Maternal Serum, and Decidua Suggests Decidua as the Primary Source of IGFBP-1 in these Fluids during Early Pregnancy J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1894 - 1898. [Abstract] [Full Text] [PDF]

				M. Westwood, J M. Gibson, and A. White Purification and Characterization of the Insulin-Like Growth Factor-Binding Protein-1 Phosphoform Found in Normal Plasma Endocrinology, March 1, 1997; 138(3): 1130 - 1136. [Abstract] [Full Text] [PDF]

				M. J. Khosravi, A. Diamandi, and J. Mistry Immunoassay of insulin-like growth factor binding protein-1 Clin. Chem., March 1, 1997; 43(3): 523 - 532. [Abstract] [Full Text] [PDF]